Emergent Health Corp
EMGE · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1,635 | $575 | $120 | $167 |
| % Growth | 184.5% | 380.6% | -28.5% | – |
| Cost of Goods Sold | $597 | $447 | $60 | $46 |
| Gross Profit | $1,038 | $128 | $59 | $121 |
| % Margin | 63.5% | 22.2% | 49.7% | 72.6% |
| R&D Expenses | $28 | $9 | $2 | $2 |
| G&A Expenses | $0 | $0 | $155 | $47 |
| SG&A Expenses | $2,418 | $1,875 | $257 | $176 |
| Sales & Mktg Exp. | $0 | $0 | $54 | $64 |
| Other Operating Expenses | $0 | $0 | $0 | $24 |
| Operating Expenses | $2,446 | $1,884 | $259 | $201 |
| Operating Income | -$1,408 | -$1,756 | -$200 | -$80 |
| % Margin | -86.1% | -305.6% | -166.9% | -47.7% |
| Other Income/Exp. Net | -$220 | -$353 | -$90 | $0 |
| Pre-Tax Income | -$1,628 | -$2,109 | -$290 | -$80 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,628 | -$2,107 | -$289 | -$79 |
| % Margin | -99.6% | -366.8% | -241.5% | -47.3% |
| EPS | -0.004 | -0.008 | -0.005 | -0.001 |
| % Growth | 50.6% | -62% | -257.1% | – |
| EPS Diluted | -0.004 | -0.008 | -0.005 | -0.001 |
| Weighted Avg Shares Out | 402,967 | 260,851 | 58,101 | 58,052 |
| Weighted Avg Shares Out Dil | 402,967 | 260,851 | 58,101 | 57,278 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $9 | $0 | $0 |
| Interest Expense | $220 | $362 | $90 | $0 |
| Depreciation & Amortization | $20 | $20 | $20 | $20 |
| EBITDA | -$1,388 | -$1,727 | -$180 | -$56 |
| % Margin | -84.9% | -300.6% | -150.2% | -33.5% |